What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D

[1]  M. Splaine,et al.  Use of the Reliable Change Index to evaluate clinical significance in SF-36 outcomes , 2002, Quality of Life Research.

[2]  W. Tierney,et al.  Using the standard error of measurement to identify important changes on the Asthma Quality of Life Questionnaire , 2002, Quality of Life Research.

[3]  S. Paisley,et al.  Methods for Determining Sample Sizes for Studies Involving Health-Related Quality of Life Measures: A Tutorial , 2001, Health Services and Outcomes Research Methodology.

[4]  B. Fridley,et al.  Practical Guidelines for Assessing the Clinical Significance of Health-Related Quality of Life Changes within Clinical Trials , 2003 .

[5]  J. Ware.  SF-36 health survey: Manual and interpretation guide , 2003 .

[6]  D. Patrick,et al.  Assessing meaningful change in quality of life over time: a users' guide for clinicians. , 2002, Mayo Clinic proceedings.

[7]  T. Rummans,et al.  The clinical significance of quality-of-life results: practical considerations for specific audiences. , 2002, Mayo Clinic proceedings.

[8]  R. Hays,et al.  Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores , 2002 .

[9]  J. Sloan,et al.  Assessing the clinical significance of single items relative to summated scores. , 2002, Mayo Clinic proceedings.

[10]  D. Cella,et al.  Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life. , 2002, Mayo Clinic proceedings.

[11]  Tara Symonds,et al.  Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms. , 2002, Mayo Clinic proceedings.

[12]  Gordon H Guyatt,et al.  Methods to explain the clinical significance of health status measures. , 2002, Mayo Clinic proceedings.

[13]  J. Brazier,et al.  The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.

[14]  Joseph C. Cappelleri,et al.  Assessing the clinical significance of single items relative to summated scores , 2002 .

[15]  R. Hays,et al.  Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores. , 2002, Mayo Clinic proceedings.

[16]  G. Guyatt,et al.  Relation of Distribution- and Anchor-Based Approaches in Interpretation of Changes in Health-Related Quality of Life , 2001, Medical care.

[17]  F Angst,et al.  Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. , 2001, Arthritis and rheumatism.

[18]  J. Brazier,et al.  Using the SF-36 with older adults: a cross-sectional community-based survey. , 2001, Age and ageing.

[19]  M. Drummond.  Introducing economic and quality of life measurements into clinical studies , 2001, Annals of medicine.

[20]  L. Morales,et al.  The RAND-36 measure of health-related quality of life , 2001, Annals of medicine.

[21]  Ad J. J. M. Vingerhoets,et al.  Quality of life assessment , 2001 .

[22]  M. Snaith,et al.  Generic and condition-specific outcome measures for people with osteoarthritis of the knee. , 1999, Rheumatology.

[23]  W M Tierney,et al.  Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. , 1999, Medical care.

[24]  J. Brazier,et al.  Deriving a preference-based single index from the UK SF-36 Health Survey. , 1998, Journal of clinical epidemiology.

[25]  C. Morrell,et al.  Cost effectiveness of community leg ulcer clinics: randomised controlled trial , 1998, BMJ.

[26]  Ron D. Hays,et al.  Quality of life assessment in clinical trials : methods and practice , 1998 .

[27]  J. Brazier,et al.  Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. , 1997, Thorax.

[28]  G. Regehr,et al.  Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. , 1997, Journal of clinical epidemiology.

[29]  J. Larson.  The MOS 36-Item Short form Health Survey , 1997, Evaluation & the health professions.

[30]  A J Morales,et al.  Quality of Life Assessment , 1996, Seminars in reproductive endocrinology.

[31]  R. Koff,et al.  Meta-analysis, decision analysis, and cost-effectiveness analysis. Methods for quantitative synthesis in medicine , 1995 .

[32]  G H Guyatt,et al.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.

[33]  R. Tibshirani,et al.  An Introduction to the Bootstrap , 1995 .

[34]  Jacob Cohen.  Statistical Power Analysis , 1992 .

[35]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[36]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .

[37]  N. Jacobson,et al.  Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. , 1991, Journal of consulting and clinical psychology.

[38]  M. Liang,et al.  Comparisons of Five Health Status Instruments for Orthopedic Evaluation , 1990, Medical care.

[39]  G. Guyatt,et al.  Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.

[40]  Lewis E. Kazis,et al.  Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.

[41]  G. Guyatt,et al.  Measuring change over time: assessing the usefulness of evaluative instruments. , 1987, Journal of chronic diseases.

[42]  M H Liang,et al.  Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. , 1985, Arthritis and rheumatism.